Form 8-K - Current report:
SEC Accession No. 0001193125-25-281657
Filing Date
2025-11-14
Accepted
2025-11-14 08:10:14
Documents
14
Period of Report
2025-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d36523d8k.htm   iXBRL 8-K 25542
2 EX-99.1 d36523dex991.htm EX-99.1 96099
6 GRAPHIC g36523snap1.jpg GRAPHIC 5432
  Complete submission text file 0001193125-25-281657.txt   255565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20251114.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20251114_lab.xml EX-101.LAB 17909
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20251114_pre.xml EX-101.PRE 11237
16 EXTRACTED XBRL INSTANCE DOCUMENT d36523d8k_htm.xml XML 3615
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 251481366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)